 The present randomized, controlled, parallel-grouped trial included twenty patients aged 20 to 54 years suffering from Millers class I or II gingival recession. Patients were randomly assigned into two equal groups; control group; the coronally advanced flap with the subepithelial connective tissue graft CAFSCTG or the test group; coronally advanced flap with amnion chorion allograft membrane CAFAC. 